MOSCOW (MRC) -- Evonik Industries is strengthening its innovative power. Last year, the specialty chemicals company increased the value of its innovation pipeline by half a billion euros, said the producer on its site.
This now places the value of the pipeline in the lower single-digit billion euro range-a figure that is expected to continue growing over the next few years. At today’s R&D press briefing in Essen, Germany, Chairman of the Executive Board of Evonik Industries Klaus Engel said: "Our innovation campaign is bearing fruit. The constant flow of new products, applications, and business models is a major driver of profitable growth at Evonik. Innovations are to make an even larger contribution to sales and profit going forward." In the medium term, the Group aims for products and applications developed in the past five years to account for over 16% of sales. Currently, these constitute around 10% of sales.
"It’s an ambitious goal," said Evonik Chief Innovation Officer Ulrich Kusthardt, "and we have taken additional steps in order to meet it." Evonik has brought its innovation portfolio into focus, redefined its growth fields, and taken the development of its innovation culture still further. Kusthardt said, "We have a total of six growth fields, which we expect to contribute over EUR1 billion in additional sales by the year 2025." These fields are in highly attractive markets where Evonik can offer new products and solutions in line with its core competencies. Examples here include sustainable nutrition, healthcare solutions, and cosmetic solutions.
Reorganizing these growth fields goes hand in hand with focusing on the innovation portfolio. The streamlined innovation portfolio now includes a more significant portion of larger innovation projects, as well as those to be carried out over the medium and long term. This will allow the company to make more efficient use of resources. Idea competitions and fostering entrepreneurship represent additional ways of improving the culture of innovation.
The planned acquisition of the specialty additives business (the Performance Materials Division) of US-based Air Products is likewise expected to strengthen Evonik’s innovative power in the field of specialty additives. Air Products’ specialty additives business employs excellent R&D personnel and maintains a powerful R&D pipeline.
"We want to become one of the most innovative companies in the world," said Kusthardt, underscoring the ambitions of the specialty chemicals company. According to a Forsa survey, nearly 50 percent of those surveyed trust Evonik to meet this goal over the medium term. Over 75% of those surveyed see Evonik as an innovative company. Early this year, Evonik contracted Forsa, an independent opinion research institute, to conduct the survey among select target groups, such as customers, investors, politicians, scientists, and employees.
As MRC wrote previously, Evonik Industries further steps up its activities in the attractive membrane business. The specialty chemicals company has recently started operating a thin-film composites plant to coat membranes for use in organic solvent nanofiltration and gas separation at its Marl site in Germany.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MRC